DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,201,482 | +3.8% | 12,904 | +0.4% | 1.61% | +6.9% |
| Q2 2023 | $3,084,000 | -1.0% | 12,850 | +4.0% | 1.51% | -3.4% |
| Q1 2023 | $3,115,214 | +98327.0% | 12,360 | +3.6% | 1.56% | -3.9% |
| Q4 2022 | $3,165 | -99.9% | 11,925 | -4.8% | 1.63% | -12.3% |
| Q3 2022 | $3,235,000 | -1.6% | 12,523 | -3.5% | 1.86% | +7.7% |
| Q2 2022 | $3,289,000 | -10.9% | 12,975 | +3.1% | 1.72% | +0.3% |
| Q1 2022 | $3,691,000 | +2.6% | 12,583 | +15.1% | 1.72% | +8.5% |
| Q4 2021 | $3,596,000 | +94.8% | 10,930 | +80.2% | 1.58% | +70.8% |
| Q3 2021 | $1,846,000 | +151.8% | 6,064 | +122.1% | 0.93% | +159.7% |
| Q2 2021 | $733,000 | +124.2% | 2,730 | +87.6% | 0.36% | +160.6% |
| Q1 2021 | $327,000 | -20.6% | 1,455 | -21.6% | 0.14% | -13.8% |
| Q4 2020 | $412,000 | +3.3% | 1,855 | 0.0% | 0.16% | -6.5% |
| Q3 2020 | $399,000 | +29.1% | 1,855 | +6.3% | 0.17% | +23.2% |
| Q2 2020 | $309,000 | +27.7% | 1,745 | 0.0% | 0.14% | +10.4% |
| Q1 2020 | $242,000 | -14.5% | 1,745 | -5.4% | 0.12% | +5.0% |
| Q4 2019 | $283,000 | +6.4% | 1,845 | 0.0% | 0.12% | -0.8% |
| Q3 2019 | $266,000 | +0.8% | 1,845 | 0.0% | 0.12% | -1.6% |
| Q2 2019 | $264,000 | +5.6% | 1,845 | -2.6% | 0.12% | +2.5% |
| Q1 2019 | $250,000 | -39.2% | 1,895 | -52.5% | 0.12% | +11.2% |
| Q4 2018 | $411,000 | +85.1% | 3,990 | +95.1% | 0.11% | +0.9% |
| Q3 2018 | $222,000 | +9.9% | 2,045 | 0.0% | 0.11% | +1.0% |
| Q2 2018 | $202,000 | -1.0% | 2,045 | -1.7% | 0.10% | -1.9% |
| Q1 2018 | $204,000 | – | 2,080 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |